Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03
Source: SeekingAlpha
2025-08-05 17:27:39 ET
More on Terns Pharmaceuticals
- Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts
- Seeking Alpha’s Quant Rating on Terns Pharmaceuticals
- Historical earnings data for Terns Pharmaceuticals
- Financial information for Terns Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03
Terns Pharmaceuticals Inc.
NASDAQ: TERN
TERN Trading
1.53% G/L:
$49.525 Last:
1,883,272 Volume:
$48.52 Open:
TERN Latest News
March 23, 2026 12:07:27 pm
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
March 18, 2026 11:04:42 am
This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish
March 16, 2026 08:13:19 pm
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
TERN Stock Data
$3,951,236,778
84,980,644
0.19%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
